Skip To Main Content
Matthew Brodsky on Muck Rack

Matthew Brodsky

As seen in: HuffPost, Nature, Fox News, The Daily Beast, The Jerusalem Post, The Times of Israel, National Review, Cell Press, The Daily Wire, The National Interest and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Matthew

Contact Matthew, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

LRRK2 -targeting antisense oligonucleotide in Parkinson’s disease: a phase 1 randomized controlled trial

|
By Omar S. Mabrouk, Ben Tichler, Eva Thoma, Sara Alexanian, Jingxian Chen, Tzu-Ying Liu, John Annand, Unnati Kapadnis, Kyle Ferber, Yuka Moroishi, Julie M Czerkowicz, Jennifer A. Inra, Ronald B. Postuma, Tanya Gurevich, Pablo Mir, Huw Morris, Jason Aldred, Matthew Brodsky, Aaron Ellenbogen, Christopher M Tolleson, Andrew Siderowf, Charalampos Tzoulis, María Martí, Hien T. Zhao, Holly B. Kordasiewicz, Roger M Lane, Warren D. Hirst, Stephanie Fradette, Danielle Graham, H. Moore Arnold, Beth Hirschhorn, Roy Llorens Arenas, Alan A. Shomo, Kelly E. Glajch, Danielle Larson, Ernest Balaguer
| Nature Verified
Abstract LRRK2 (encoding leucine-rich repeat kinase 2) variants are the most common genetic cause of Parkinson’s disease (PD). Lowering LRRK2 levels and/or inhibiting LRRK2 activity may modify PD-associated neuropathology. BIIB094 (ION859), an antisense oligonucleotide, targets LRRK2 mRNA for degradation. REASON was a first-in-human randomized phase 1 study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intrathecal BIIB094 in patients with PD.
Open in Who Shared Issue with article?

AI impact on political misinformation

|
By Matthew Brodsky, Nate Harrington Verified
| The NewsHouse Verified
A wave of public concern over the influence of artificial intelligence on misinformation and the democratic process has emerged as the countdown to the upcoming election season begins. Citizens and experts are raising questions about the role and regulation of AI technology in shaping political advertising. “There’s a growing portion of people who agree that AI needs to be carefully managed,” researcher Baobao Zhang said.
Open in Who Shared Issue with article?

Deep fakes and AI are reinventing seeing and believing

|
By Alex Battaglia, Matthew Brodsky
| The NewsHouse Verified
The Pope is wearing a Balenciaga jacket and chain, Taylor Swift has no sympathy for her “poor” fans who can’t afford her tickets, and the Republican National Committee has already begun to produce AI-generated election ads targeting President Biden’s campaign. Welcome to 2023. Artificial Intelligence and deep fakes have been surfacing across the internet for several years now. But as technology advances, it has become harder and harder to detect what’s real and what has been fabricated.
Open in Who Shared Issue with article?
See all 173 licensed articles (186 Total)